Enzyme that converts testosterone to estrogen has big role in the healthy, injured brain
An enzyme that converts testosterone to estrogen appears to have significant impact in a healthy and injured brain, scientists report.
May 4, 2015
0
49
An enzyme that converts testosterone to estrogen appears to have significant impact in a healthy and injured brain, scientists report.
May 4, 2015
0
49
Household net worth is a major and overlooked factor in adherence to hormonal therapy among breast cancer patients and partially explains racial disparities in quality of care. The findings suggest that physicians, health ...
Feb 24, 2015
0
31
(HealthDay)—Exercise helps relieve aromatase inhibitor (AI)-induced pain in breast cancer survivors, according to research published online Dec. 1 in the Journal of Clinical Oncology.
Dec 10, 2014
0
0
A new combination of cancer drugs delayed disease progression for patients with hormone-receptor-positive metastatic breast cancer, according to a multi-center phase II trial. The findings of the randomized study (S6-03) ...
Dec 10, 2014
0
0
Although oral hormonal therapy is known to substantially reduce breast cancer recurrence in women with hormone receptor–positive tumors, about one-half of patients fail to take their medications as directed. A study by ...
Oct 28, 2014
0
0
Discontinuation and nonadherence were higher among breast cancer patients taking brand name aromatase inhibitors (BAIs) vs generic AIs (GAIs), according to a new study published October 27 in the JNCI: Journal of the National ...
Oct 27, 2014
0
0
Breast cancer experts around the world have issued a plea to researchers, academics, drug companies, funders and advocates to carry out high quality research and clinical trials for advanced breast cancer, a disease which ...
Sep 18, 2014
0
0
(Medical Xpress)—Obesity may affect a common drug that is used as part of the treatment to fight breast cancer in post-menopausal women.
Aug 22, 2014
0
0
One of the most comprehensive looks at the use of hormone therapy in women over 65 with non-metastatic breast cancer found some welcome news. Except for frail patients, most participants in the large study complied with their ...
Jun 16, 2014
0
0
A breast cancer therapy that blocks estrogen synthesis to activate cancer-killing genes sometimes loses its effectiveness because the cancer takes over epigenetic mechanisms, including permanent DNA modifications in the patient's ...
Mar 26, 2014
0
0